To evaluate the role c-Met expression could have in predicting susceptibility of breast cancer cells to ASCs, we evaluated expression levels of c-Met in primary breast cancer cells isolated from eleven human donors which were co-injected with autologous ASCs into immuno-compromised mice to assess tumorigenicity. This evidence concerns the gene MET and breast cancer.